The Peptide Encyclopedia

Abaloparatide (also known as Tymlos) is a peptide catalogued under Hormones & Metabolic (PTHrP analog). It is described as: PTH1R (RG-selective). Documented context: Osteoporosis. Neutral reference entry; EU status: EU-approved prescription medicine.

Adrenocorticotropic hormone (also known as ACTH) is a peptide catalogued under Hormones & Metabolic (Pituitary hormone). It is described as: MC2 receptor. Documented context: Multiple sclerose; nefrotisch syndroom; infantiele spasmen. Neutral reference entry; EU status: EU-approved prescription medicine.

A 32-amino-acid peptide hormone, FDA-approved for postmenopausal osteoporosis, Paget disease and hypercalcemia; now a later-line option.

Cosyntropin (also known as Tetracosactide) is a peptide catalogued under Hormones & Metabolic (ACTH analog (1-24)). It is described as: MC2 receptor. Documented context: Diagnostic (adrenal function). Neutral reference entry; EU status: EU-approved prescription medicine.

Dasiglucagon (also known as Zegalogue) is a peptide catalogued under Hormones & Metabolic (Glucagon analog). It is described as: Glucagon receptor agonist. Documented context: Severe hypoglycemia. Neutral reference entry; EU status: EU-approved prescription medicine.

Glucagon (also known as GlucaGen) is a peptide catalogued under Hormones & Metabolic (Pancreatic hormone). It is described as: Glucagon receptor. Documented context: Severe hypoglycemia. Neutral reference entry; EU status: EU-approved prescription medicine.

Insulin aspart (also known as NovoLog) is a peptide catalogued under Hormones & Metabolic (Rapid-acting insulin analogue). It is described as: Insulin receptor agonist. Documented context: Diabetes mellitus. Neutral reference entry; EU status: EU-approved prescription medicine.

Insulin degludec (also known as Tresiba) is a peptide catalogued under Hormones & Metabolic (Ultra-long-acting insulin). It is described as: Insulin receptor agonist. Documented context: Diabetes mellitus. Neutral reference entry; EU status: EU-approved prescription medicine.

Insulin degludec/aspart (also known as Ryzodeg) is a peptide catalogued under Hormones & Metabolic (Insulin combination). It is described as: Insulin receptor agonist. Documented context: Diabetes mellitus. Neutral reference entry; EU status: EU-approved prescription medicine.

Insulin detemir (also known as Levemir) is a peptide catalogued under Hormones & Metabolic (Long-acting insulin analogue). It is described as: Insulin receptor agonist. Documented context: Diabetes mellitus. Neutral reference entry; EU status: EU-approved prescription medicine.

Insulin glargine (also known as Lantus) is a peptide catalogued under Hormones & Metabolic (Long-acting insulin analogue). It is described as: Insulin receptor agonist. Documented context: Diabetes mellitus. Neutral reference entry; EU status: EU-approved prescription medicine.

Insulin glulisine (also known as Apidra) is a peptide catalogued under Hormones & Metabolic (Rapid-acting insulin analogue). It is described as: Insulin receptor agonist. Documented context: Diabetes mellitus. Neutral reference entry; EU status: EU-approved prescription medicine.

Insulin human (also known as Regular insulin) is a peptide catalogued under Hormones & Metabolic (Insulin). It is described as: Insulin receptor agonist. Documented context: Diabetes mellitus. Neutral reference entry; EU status: EU-approved prescription medicine.

Insulin icodec (also known as Awiqli) is a peptide catalogued under Hormones & Metabolic (Once-weekly basal insulin). It is described as: Insulin receptor agonist. Documented context: Type 2 diabetes. Neutral reference entry; EU status: EU-approved prescription medicine.

Insulin lispro (also known as Humalog) is a peptide catalogued under Hormones & Metabolic (Rapid-acting insulin analogue). It is described as: Insulin receptor agonist. Documented context: Diabetes mellitus. Neutral reference entry; EU status: EU-approved prescription medicine.

Lanreotide (also known as Somatuline) is a peptide catalogued under Hormones & Metabolic (Somatostatin analog). It is described as: SSTR2/5. Documented context: Acromegaly; neuroendocrine tumors. Neutral reference entry; EU status: EU-approved prescription medicine.

Recombinant human B-type natriuretic peptide, FDA-approved (2001) for acute decompensated heart failure but largely abandoned after neutral outcome trials.

NPH insulin (also known as Isophane insulin) is a peptide catalogued under Hormones & Metabolic (Intermediate-acting insulin). It is described as: Insulin receptor agonist. Documented context: Diabetes mellitus. Neutral reference entry; EU status: EU-approved prescription medicine.

Octreotide (also known as Sandostatin) is a peptide catalogued under Hormones & Metabolic (Somatostatin analog). It is described as: SSTR2/5. Documented context: Acromegaly; carcinoid tumor; VIPoma. Neutral reference entry; EU status: EU-approved prescription medicine.

Palopegteriparatide (also known as TransCon PTH) is a peptide catalogued under Hormones & Metabolic (Long-acting PTH prodrug). It is described as: PTH1R. Documented context: Hypoparathyroidism. Neutral reference entry; EU status: EU-approved prescription medicine.

Parathyroid hormone (also known as PTH) is a peptide catalogued under Hormones & Metabolic (Full-length rhPTH (1-84)). It is described as: PTH1R. Documented context: Hypoparathyroidism. Neutral reference entry; EU status: EU-approved prescription medicine.

Pasireotide (also known as Signifor) is a peptide catalogued under Hormones & Metabolic (Multi-receptor somatostatin analog). It is described as: SSTR1/2/3/5. Documented context: Cushing disease; acromegaly. Neutral reference entry; EU status: EU-approved prescription medicine.

Pegvisomant (also known as Somavert) is a peptide catalogued under Hormones & Metabolic (GH receptor antagonist (PEGylated)). It is described as: GH receptor antagonist. Documented context: Acromegaly. Neutral reference entry; EU status: EU-approved prescription medicine.

Salmon calcitonin (also known as Miacalcin) is a peptide catalogued under Hormones & Metabolic (Calcitonin analog). It is described as: Calcitonin receptor agonist. Documented context: Osteoporosis; Paget disease; hypercalcemia. Neutral reference entry; EU status: EU-approved prescription medicine.

Somapacitan (also known as Sogroya) is a peptide catalogued under Hormones & Metabolic (Long-acting GH analog). It is described as: GH receptor. Documented context: GHD adults/children. Neutral reference entry; EU status: EU-approved prescription medicine.

Somatostatin (also known as SST) is a peptide catalogued under Hormones & Metabolic (Somatostatin). It is described as: Somatostatin receptors (SSTR1-5). Documented context: GI bleeding; endocrine tumors. Neutral reference entry; EU status: EU-approved prescription medicine.

Teriparatide (also known as Forteo) is a peptide catalogued under Hormones & Metabolic (PTH analog). It is described as: PTH1R. Documented context: Osteoporosis. Neutral reference entry; EU status: EU-approved prescription medicine.

Thyrotropin alfa (also known as Thyrogen) is a peptide catalogued under Hormones & Metabolic (Recombinant TSH). Neutral reference entry; EU status: EU-approved prescription medicine.

Thyrotropin-releasing hormone (also known as TRH) is a peptide catalogued under Hormones & Metabolic (Hypothalamic tripeptide). It is described as: TRH receptor. Documented context: Diagnostic. Neutral reference entry; EU status: EU-approved prescription medicine.